grant

Social Health Factors Associated with the Transition from Acute to Chronic Low Back Pain

Organization DUKE UNIVERSITYLocation DURHAM, UNITED STATESPosted 6 Sept 2024Deadline 5 Sept 2027
NIHUS FederalResearch GrantFY2025(TNF)-α21+ years oldAcuteAddressAdultAdult HumanAffectAfrican AmericanAfro AmericanAfroamericanAnatomic SitesAnatomic structuresAnatomyAnti-InflammatoriesAnti-Inflammatory AgentsAnti-inflammatoryAreaAttenuatedBiologic FactorBiologicalBiological FactorsBiologyBiometricsBiometryBiostatisticsBlackBlack AmericanBlack raceBlood CellsBlood PlasmaBlood monocyteCD14CD14 geneCD16CD16BCachectinCell BodyCellsChronicChronic low back painClinicalCommunitiesCounselingDataDedicationsDevelopmentDimensionsDisparitiesDisparityDown-RegulationEndogenous Interferon BetaEpidemiologyExposure toFCGR3BFCGR3B geneFc Receptor III-1Fc gamma IIIb receptorFc-Gamma RIII-BetaFc-Gamma RIIIBFcRIIIBFibroblast InterferonFrequenciesFundingGoalsHealthHigh PrevalenceIFNIFN-βIFNbIgG Fc Receptor IIIBImmuneImmune mediated therapyImmune responseImmune systemImmunesImmunobiologyImmunologically Directed TherapyImmunologyImmunophysiologyImmunotherapyIncidenceIndividualIndividuals from minorityIndividuals of minorityInflammatoryInflammatory ResponseInstitute of MedicineInstitute of Medicine (U.S.)Interferon-βInterferonsInterventionInvestigatorsKnowledgeLow Affinity IgG Fc Receptor IIIBLow Affinity Immunoglobulin Gamma Fc Region Receptor III-BLow Back AcheLow Back PainLow BackacheLumbagoMacrophage-Derived TNFMarrow monocyteMeasuresMentorshipMinority GroupsMinority PeopleMinority PopulationMinority individualModelingMonocyte-Derived TNFMusculoskeletal PainNAS/IOMNational Institutes of HealthNatural Interferon BetaNatural human interferon betaOutcomePainPain ControlPain TherapyPain intensityPain interferencePain managementPainfulParticipantPathway interactionsPatient Self-ReportPatientsPeripheral Blood CellPhenotypePlasmaPlasma SerumPositionPositioning AttributePrevalencePsychological FactorsRaceRacesRacial GroupReportingResearchResearch PersonnelResearch ResourcesResearchersResourcesReticuloendothelial System, Serum, PlasmaRisk FactorsRoleSamplingSelf-ReportSeveritiesSocial isolationSocial statusSocial stratificationSociologySubgroupTNFTNF ATNF AlphaTNF geneTNF-αTNFATNFαTumor Necrosis FactorTumor Necrosis Factor-alphaUnited StatesUnited States National Institutes of HealthUpregulationWorkacute to chronic pain transitionadulthoodattenuateattenuatesbiologiccare resourcescareerchronic painchronic pain transitioncostcytokinedevelopmentaldifferences due to racedifferences in racediffers by racediffers in racedisparities in racedisparity due to racedisparity in healtheffective therapyeffective treatmentepidemiologicepidemiologicalexperiencehealth care resourceshealth disparityhigh riskhost responseimmune system functionimmune system responseimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimmunoresponseinequality due to raceinequity due to raceinnovateinnovationinnovativeinsightmonocytenovelolder adultolder adulthoodpain chronificationpain interventionpain outcomepain scorepain treatmentpain-related outcomepathwayphenotypic biomarkerphenotypic markerpreventpreventingpsychologicpsychologicalrace based differencesrace based disparityrace based inequalityrace based inequityrace differencesrace disparityrace related differencesrace related disparityrace related inequalityrace related inequityracialracial backgroundracial differenceracial disparityracial identityracial inequalityracial inequityracial originracial populationracial subgroupracially differentracially unequalsocialsocial engagementsocial factorssocial health determinantssocial involvementsocial participationsocial positionsocial rolesocial standingsocio-demographic factorssocio-demographicssociodemographic factorssociodemographicstransition to chronic painyears lived with disability
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY AND ABSTRACT
Chronic low back pain (LBP) is extremely common worldwide yet poorly understood due to its multidimensional

complexity of biological, psychological, and sociological factors. Social determinants of health are non-medical

factors that influence health outcomes and can be measured partly by sociodemographic factors and social

health factors (i.e., social isolation, social participation, and social roles). An individual’s social factors may

interact with that individual’s biology during an acute LBP episode by influencing specific immune responses,

which may provide two pathways for interventions to prevent the development of chronic LBP. The goal of this

proposed project is to elucidate the relationship between social and biological factors’ influence on the transition

from acute to chronic LBP. To achieve this goal, we will use extant data on participants experiencing an episode

of acute LBP and determine if sociodemographic and social health factors influence the transition to chronic LBP

at three months. Then we will begin exploring the role of the immune system in this model by cross-sectionally

examining the association between social factors and the immune system during an acute episode of LBP. The

overall hypothesis of this proposal is that social factors are directly associated with the transition from acute

to chronic LBP and may influence biological pathways initiated during an acute episode of LBP. This

proposal will achieve the goals of the proposed study in three specific aims: first, by determining if race or racial

identity is associated with the transition from acute to chronic LBP; second, by determining if social health factors

are associated with the transition from acute to chronic LBP, as well as examining the potential moderating effect

of race on this relationship; third, by identifying the relationships between social factors and the immune system

during acute LBP. These aims will advance our knowledge of risk factors for developing chronic LBP. The

proposed work will have broad clinical implications for treating, managing, and/or preventing chronic LBP through

potential targeted treatments of social health risk factors (i.e., isolation, roles, or participation) or potential

immunotherapy treatments for sub-groups (i.e., race) at high risk for transition to chronic LBP.

Grant Number: 5F31AR084911-02
NIH Institute/Center: NIH

Principal Investigator: Colleen Burke

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →